Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.48) per share. This is a 29.73 percent decrease over losses of $(0.37) per share from the same period last year.
Related Posts
Cava Group Shares Sizzle In First Day Of NYSE Trading
The first restaurant IPO in some time kicked off with a bang Thursday, as shares of Cava Group (NYSE: CAVA) soared from their initial price and saw a surge of interest from traders and investors.
Understanding How Stablecoins Have Fared In The Crypto Bear Phase
Cryptocurrencies have long been considered a hedge against inflation and a better alternative to fiat currencies that are susceptible to devaluation concerns. Most cryptocurrencies have significantly underperformed benchmark stock market indices due to liquidity pressures brought about by the tightening of monetary policy by leading central banks such as the U.S. Federal Reserve.
Here’s How Much $1000 Invested In Home Depot 15 Years Ago Would Be Worth Today
Home Depot (NYSE:HD) has outperformed the market over the past 15 years by 11.26% on an annualized basis…